Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04232345 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT04232345 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 32 participants.
The verdict
NCT04232345, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is randomized, single-blind, placebo-controlled Phase 1 study aimed to assess the safety and efficacy, pharmacokinetics and pharmacodynamics of multiple doses of oral AZD4831 in healthy Japanese and Chinese volunteers
Interventions
- DRUG Placebo
- DRUG AZD4831
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2021-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04232345
The ClinicalTrials.gov registry entry for NCT04232345 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04232345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04232345 about?
NCT04232345 is a clinical study titled "A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers". This study is randomized, single-blind, placebo-controlled Phase 1 study aimed to assess the safety and efficacy, pharmacokinetics and pharmacodynamics of multiple doses of oral AZD4831 in healthy Japanese and Chinese volunteers
What is the current status of trial NCT04232345?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2020-01-16. Estimated completion is 2021-03-11.
What interventions are being tested in trial NCT04232345?
The interventions under investigation include: Placebo (DRUG), AZD4831 (DRUG).
Who is sponsoring clinical trial NCT04232345?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.